|
1
|
Trotta BM, Pease CS, Rasamny JJ, Raghavan
P and Mukherjee S: Oral cavity and oropharyngeal squamous cell
cancer: Key imaging findings for staging and treatment planning.
Radiographics. 31:339–354. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nair S and Pillai MR: Human papillomavirus
and disease mechanisms: Relevance to oral and cervical cancers.
Oral Dis. 11:350–359. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kamangar F, Dores GM and Anderson WF:
Patterns of cancer incidence, mortality, and prevalence across five
continents: Defining priorities to reduce cancer disparities in
different geographic regions of the world. J Clin Oncol.
24:2137–2150. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Esteller M: Non-coding RNAs in human
disease. Nat Rev Genet. 12:861–874. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu HH, Lin WC and Tsai KW: Advances in
molecular biomarkers for gastric cancer: miRNAs as emerging novel
cancer markers. Expert Rev Mol Med. 16:e12014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Avissar M, McClean MD, Kelsey KT and
Marsit CJ: MicroRNA expression in head and neck cancer associates
with alcohol consumption and survival. Carcinogenesis.
30:2059–2063. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Banerjee R, Mani RS, Russo N, Scanlon CS,
Tsodikov A, Jing X, Cao Q, Palanisamy N, Metwally T, Inglehart RC,
et al: The tumor suppressor gene rap1GAP is silenced by
miR-101-mediated EZH2 overexpression in invasive squamous cell
carcinoma. Oncogene. 30:4339–4349. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gee HE, Camps C, Buffa FM, Patiar S,
Winter SC, Betts G, Homer J, Corbridge R, Cox G, West CM, et al:
Hsa-mir-210 is a marker of tumor hypoxia and a prognostic factor in
head and neck cancer. Cancer. 116:2148–2158. 2010.PubMed/NCBI
|
|
10
|
Hebert C, Norris K, Scheper MA, Nikitakis
N and Sauk JJ: High mobility group A2 is a target for miRNA-98 in
head and neck squamous cell carcinoma. Mol Cancer. 6:52007.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Liu CJ, Tsai MM, Hung PS, Kao SY, Liu TY,
Wu KJ, Chiou SH, Lin SC and Chang KW: miR-31 ablates expression of
the HIF regulatory factor FIH to activate the HIF pathway in head
and neck carcinoma. Cancer Res. 70:1635–1644. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Liu X, Jiang L, Wang A, Yu J, Shi F and
Zhou X: MicroRNA-138 suppresses invasion and promotes apoptosis in
head and neck squamous cell carcinoma cell lines. Cancer Lett.
286:217–222. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Lu YC, Chen YJ, Wang HM, Tsai CY, Chen WH,
Huang YC, Fan KH, Tsai CN, Huang SF, Kang CJ, et al: Oncogenic
function and early detection potential of miRNA-10b in oral cancer
as identified by microRNA profiling. Cancer Prev Res (Phila).
5:665–674. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Peschiaroli A, Giacobbe A, Formosa A,
Markert EK, Bongiorno-Borbone L, Levine AJ, Candi E, D'Alessandro
A, Zolla L, Finazzi Agrò A and Melino G: miR-143 regulates
hexokinase 2 expression in cancer cells. Oncogene. 32:797–802.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wong TS, Liu XB, Wong BY, Ng RW, Yuen AP
and Wei WI: Mature miR-184 as potential oncogenic microRNA of
squamous cell carcinoma of tongue. Clin Cancer Res. 14:2588–2592.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yang CJ, Shen WG, Liu CJ, Chen YW, Lu HH,
Tsai MM and Lin SC: miR-221 and miR-222 expression increased the
growth and tumorigenesis of oral carcinoma cells. J Oral Pathol
Med. 40:560–566. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yekta S, Shih IH and Bartel DP:
MicroRNA-directed cleavage of HOXB8 mRNA. Science. 304:594–596.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Hornstein E, Mansfield JH, Yekta S, Hu JK,
Harfe BD, McManus MT, Baskerville S, Bartel DP and Tabin CJ: The
microRNA miR-196 acts upstream of Hoxb8 and Shh in limb
development. Nature. 438:671–674. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Tsai KW, Hu LY, Wu CW, Li SC, Lai CH, Kao
HW, Fang WL and Lin WC: Epigenetic regulation of miR-196b
expression in gastric cancer. Genes Chromosomes Cancer. 49:969–980.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liao YL, Hu LY, Tsai KW, Wu CW, Chan WC,
Li SC, Lai CH, Ho MR, Fang WL, Huang KH and Lin WC: Transcriptional
regulation of miR-196b by ETS2 in gastric cancer cells.
Carcinogenesis. 33:760–769. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Tsai KW, Liao YL, Wu CW, Hu LY, Li SC,
Chan WC, Ho MR, Lai CH, Kao HW, Fang WL, et al: Aberrant expression
of miR-196a in gastric cancers and correlation with recurrence.
Genes Chromosomes Cancer. 51:394–401. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Lim JY, Yoon SO, Seol SY, Hong SW, Kim JW,
Choi SH, Lee JS and Cho JY: Overexpression of miR-196b and HOXA10
characterize a poor-prognosis gastric cancer subtype. World J
Gastroenterol. 19:7078–7088. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Luthra R, Singh RR, Luthra MG, Li YX,
Hannah C, Romans AM, Barkoh BA, Chen SS, Ensor J, Maru DM, et al:
MicroRNA-196a targets annexin A1: A microRNA-mediated mechanism of
annexin A1 downregulation in cancers. Oncogene. 27:6667–6678. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Bhatia S, Kaul D and Varma N: Functional
genomics of tumor suppressor miR-196b in T-cell acute lymphoblastic
leukemia. Mol Cell Biochem. 346:103–116. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Coskun E, von der Heide EK, Schlee C,
Kühnl A, Gökbuget N, Hoelzer D, Hofmann WK, Thiel E and Baldus CD:
The role of microRNA-196a and microRNA-196b as ERG regulators in
acute myeloid leukemia and acute T-lymphoblastic leukemia. Leuk
Res. 35:208–213. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
How C, Hui AB, Alajez NM, Shi W, Boutros
PC, Clarke BA, Yan R, Pintilie M, Fyles A, Hedley DW, et al:
MicroRNA-196b regulates the homeobox B7-vascular endothelial growth
factor axis in cervical cancer. PLoS One. 8:e678462013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li Y, Zhang M, Chen H, Dong Z, Ganapathy
V, Thangaraju M and Huang S: Ratio of miR-196s to HOXC8 messenger
RNA correlates with breast cancer cell migration and metastasis.
Cancer Res. 70:7894–7904. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lu YC, Chang JT, Liao CT, Kang CJ, Huang
SF, Chen IH, Huang CC, Huang YC, Chen WH, Tsai CY, et al:
OncomiR-196 promotes an invasive phenotype in oral cancer through
the NME4-JNK-TIMP1-MMP signaling pathway. Mol Cancer. 13:2182014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Greene FL, Page DL, Fleming ID, Fritz AG,
Balch CM, Haller DG and Morrow M: AJCC Cancer Staging Manual (6th).
Springer. New York, NY: 2002. View Article : Google Scholar
|
|
30
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Popovic R, Riesbeck LE, Velu CS, Chaubey
A, Zhang J, Achille NJ, Erfurth FE, Eaton K, Lu J, Grimes HL, et
al: Regulation of mir-196b by MLL and its overexpression by MLL
fusions contributes to immortalization. Blood. 113:3314–3322. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Velu CS, Baktula AM and Grimes HL: Gfi1
regulates miR-21 and miR-196b to control myelopoiesis. Blood.
113:4720–4728. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Ma R, Yan W, Zhang G, Lv H, Liu Z, Fang F,
Zhang W, Zhang J, Tao T, You Y, et al: Upregulation of miR-196b
confers a poor prognosis in glioblastoma patients via inducing a
proliferative phenotype. PLoS One. 7:e380962012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Liu Y, Zheng W, Song Y, Ma W and Yin H:
Low expression of miR-196b enhances the expression of BCR-ABL1 and
HOXA9 oncogenes in chronic myeloid leukemogenesis. PLoS One.
8:e684422013. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Abe W, Nasu K, Nakada C, Kawano Y,
Moriyama M and Narahara H: miR-196b targets c-myc and Bcl-2
expression, inhibits proliferation and induces apoptosis in
endometriotic stromal cells. Hum Reprod. 28:750–761. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Li Z, Huang H, Chen P, He M, Li Y,
Arnovitz S, Jiang X, He C, Hyjek E, Zhang J, et al: miR-196b
directly targets both HOXA9/MEIS1 oncogenes and FAS tumour
suppressor in MLL-rearranged leukaemia. Nat Commun. 3:6882012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Inokawa Y, Nomoto S, Hishida M, Hayashi M,
Kanda M, Nishikawa Y, Takeda S, Sugimoto H, Fujii T, Yamada S and
Kodera Y: Detection of doublecortin domain-containing 2 (DCDC2), a
new candidate tumor suppressor gene of hepatocellular carcinoma, by
triple combination array analysis. J Exp Clin Cancer Res.
32:652013. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Qi L and Zhang Y: Truncation of inhibitor
of growth family protein 5 effectively induces senescence, but not
apoptosis in human tongue squamous cell carcinoma cell line. Tumour
Biol. 35:3139–3144. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Asim M, Hafeez BB, Siddiqui IA, Gerlach C,
Patz M, Mukhtar H and Baniahmad A: Ligand-dependent corepressor
acts as a novel androgen receptor corepressor, inhibits prostate
cancer growth, and is functionally inactivated by the Src protein
kinase. J Biol Chem. 286:37108–37117. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Wen H, Li Y, Xi Y, Jiang S, Stratton S,
Peng D, Tanaka K, Ren Y, Xia Z, Wu J, et al: ZMYND11 links histone
H3.3K36me3 to transcription elongation and tumour suppression.
Nature. 508:263–268. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Lu YC, Chang JT, Huang YC, Huang CC, Chen
WH, Lee LY, Huang BS, Chen YJ, Li HF and Cheng AJ: Combined
determination of circulating miR-196a and miR-196b levels produces
high sensitivity and specificity for early detection of oral
cancer. Clin Biochem. 48:115–121. 2015. View Article : Google Scholar : PubMed/NCBI
|
